查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1672051

全球气喘治疗市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Asthma Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格

全球气喘治疗市场规模预计将从 2024 年的 331.9 亿美元成长到 2033 年的 513.6 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 4.97%。

受气喘盛行率不断上升和对有效治疗方案的需求不断增加的推动，气喘治疗市场正在经历大幅成长。随着人们对气喘管理认识的提高，医疗保健提供者正专注于针对每位患者的独特需求的个人化治疗计划。气喘治疗领域的创新，包括生物製剂和标靶治疗，正在改变气喘管理的格局，为患有严重且无法控制的气喘患者带来新的希望。智慧吸入器和数位健康解决方案的发展补充了这些进步，增强了药物依从性和监测能力。

此外，对预防保健和早期介入的日益重视正在影响气喘治疗市场。随着医疗保健系统优先考虑主动管理策略，对有效气喘药物的需求正在激增。此外，对病患教育和自我管理的日益关注使患者能够控制自己的气喘，从而改善治疗效果并降低医疗成本。

此外，远距医疗和远端监控技术的兴起有助于更好地管理气喘。患者现在无需亲自前往医院即可联繫医疗专业人员进行咨询和跟进，从而更轻鬆地管理自己的病情。这一趋势在新冠肺炎疫情的背景下尤其重要，远距照护已变得至关重要。总之，气喘治疗市场将实现强劲成长，其特点是创新、注重个人化护理以及致力于改善气喘患者的生活品质。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

报告涵盖的细分

按药物类别

  • 联合疗法 (ICS/LABA)
  • 长效β受体激动剂 (LABA)
  • 短效 β 受体激动剂 (SABA)
  • 吸入性皮质类固醇 (ICS)
  • 口服和静脉注射皮质类固醇
  • 白三烯调节剂
  • 其他

按治疗类型

  • 长期气喘控制药物
  • 快速缓解（救援）药物

依给药途径

  • 主题
  • 口服
  • 注射剂

按配销通路

  • 实体店面
  • 医院药房
  • 电子商务

按最终用途

  • 医院和诊所
  • 门诊手术中心
  • 家庭护理设置
  • 公司简介
  • 阿斯利康
  • 勃林格殷格翰
  • 西普拉有限公司
  • 科维斯製药
  • 葛兰素史克公司
  • 默克公司
  • 诺华製药公司
  • 再生元製药公司（Regeneron Pharmaceuticals Inc.）
  • 赛诺菲
  • 梯瓦製药工业股份有限公司
  • 以上清单可以自订。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：气喘治疗产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按药品类别进行市场吸引力分析
    • 依治疗类型进行市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 按配销通路进行市场吸引力分析
    • 按最终用途进行的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球气喘治疗市场分析：依药物类别

  • 按药物类别概述
  • 按药物类别进行的历史和预测数据分析
  • 联合疗法 (ICS/LABA)
  • 长效β受体激动剂 (LABA)
  • 短效 β 受体激动剂 (SABA)
  • 吸入性皮质类固醇 (ICS)
  • 口服和静脉注射皮质类固醇
  • 白三烯调节剂
  • 其他

第 6 章：全球气喘治疗市场分析：依治疗类型

  • 按治疗类型概述
  • 按治疗类型进行的历史和预测数据分析
  • 长期气喘控制药物
  • 快速缓解（救援）药物

第 7 章：全球气喘治疗市场分析：依给药途径

  • 依给药途径概述
  • 按给药途径进行的历史和预测数据分析
  • 主题
  • 口服
  • 注射剂

第 8 章：全球气喘治疗市场分析：按分销管道

  • 按配销通路概览
  • 按配销通路进行的历史和预测资料分析
  • 实体店面
  • 医院药房
  • 电子商务

第 9 章：全球气喘治疗市场分析：依最终用途

  • 按最终用途概述
  • 按最终用途进行的历史和预测数据分析
  • 医院和诊所
  • 门诊手术中心
  • 家庭护理设置

第 10 章：全球气喘治疗市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 11 章：气喘治疗公司的竞争格局

  • 气喘治疗市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 12 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • AstraZeneca
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cipla Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Covis Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GSK Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis Pharmaceuticals Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Regeneron Pharmaceuticals Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceutical Industries Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11217451

Global Asthma Therapeutics Market size is anticipated to grow from USD 33.19 Billion in 2024 to USD 51.36 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The asthma therapeutics market is experiencing substantial growth, driven by the increasing prevalence of asthma and the rising demand for effective treatment options. As awareness of asthma management improves, healthcare providers are focusing on personalized treatment plans that address the unique needs of each patient. Innovations in asthma therapeutics, including biologics and targeted therapies, are transforming the landscape of asthma management, offering new hope for patients with severe and uncontrolled asthma. These advancements are complemented by the development of smart inhalers and digital health solutions that enhance medication adherence and monitoring.

Moreover, the growing emphasis on preventive care and early intervention is influencing the asthma therapeutics market. As healthcare systems prioritize proactive management strategies, the demand for effective asthma medications is surging. Additionally, the increasing focus on patient education and self-management is empowering individuals to take control of their asthma, leading to improved outcomes and reduced healthcare costs.

Furthermore, the rise of telemedicine and remote monitoring technologies is facilitating better asthma management. Patients can now access healthcare professionals for consultations and follow-ups without the need for in-person visits, making it easier to manage their condition. This trend is particularly relevant in the context of the COVID-19 pandemic, where remote care has become essential. In conclusion, the asthma therapeutics market is set for robust growth, characterized by innovation, a focus on personalized care, and a commitment to improving the quality of life for asthma patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Drug Class

  • Combination Therapies (ICS/LABAs)
  • Long-Acting Beta Agonists (LABAs)
  • Short-Acting Beta Agonists (SABAs)
  • Inhaled Corticosteroids (ICS)
  • Oral and Intravenous Corticosteroids
  • Leukotriene Modifiers
  • Other

By Treatment Type

  • Long-Term Asthma Control Medications
  • Quick-Relief (Rescue) Medications

By Route of Administration

  • Topical
  • Oral
  • Injectables

By Distribution Channel

  • Brick & Mortar
  • Hospital Pharmacies
  • E-Commerce

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • COMPANIES PROFILED
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Ltd.
  • Covis Pharma
  • GSK plc
  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ASTHMA THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Class
    • 3.7.2 Market Attractiveness Analysis By Treatment Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By End-Use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 5.1. Overview By Drug Class
  • 5.2. Historical and Forecast Data Analysis By Drug Class
  • 5.3. Combination Therapies (ICS/LABAs) Historic and Forecast Sales By Regions
  • 5.4. Long-Acting Beta Agonists (LABAs) Historic and Forecast Sales By Regions
  • 5.5. Short-Acting Beta Agonists (SABAs) Historic and Forecast Sales By Regions
  • 5.6. Inhaled Corticosteroids (ICS) Historic and Forecast Sales By Regions
  • 5.7. Oral And Intravenous Corticosteroids Historic and Forecast Sales By Regions
  • 5.8. Leukotriene Modifiers Historic and Forecast Sales By Regions
  • 5.9. Other Historic and Forecast Sales By Regions

6. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 6.1. Overview By Treatment Type
  • 6.2. Historical and Forecast Data Analysis By Treatment Type
  • 6.3. Long-Term Asthma Control Medications Historic and Forecast Sales By Regions
  • 6.4. Quick-Relief (Rescue) Medications Historic and Forecast Sales By Regions

7. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1. Overview By Route Of Administration
  • 7.2. Historical and Forecast Data Analysis By Route Of Administration
  • 7.3. Topical Historic and Forecast Sales By Regions
  • 7.4. Oral Historic and Forecast Sales By Regions
  • 7.5. Injectables Historic and Forecast Sales By Regions

8. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Brick & Mortar Historic and Forecast Sales By Regions
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. E-Commerce Historic and Forecast Sales By Regions

9. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-Use
  • 9.2. Historical and Forecast Data Analysis By End-Use
  • 9.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 9.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 9.5. Homecare Settings Historic and Forecast Sales By Regions

10. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ASTHMA THERAPEUTICS COMPANIES

  • 11.1. Asthma Therapeutics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF ASTHMA THERAPEUTICS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. AstraZeneca
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Cipla Ltd.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Covis Pharma
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GSK Plc
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Merck & Co. Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Novartis Pharmaceuticals Corporation
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Regeneron Pharmaceuticals Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Sanofi
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Teva Pharmaceutical Industries Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Asthma Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Asthma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Asthma Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Treatment Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.